BRPI0923032A2 - utilização de um concentrado de imuno globulinas g (igg) pobre em anticorpos anti-a e anti-b para o tratamento do icterícia neonatal por incompatibilidade fetomaternal no sistema abo - Google Patents

utilização de um concentrado de imuno globulinas g (igg) pobre em anticorpos anti-a e anti-b para o tratamento do icterícia neonatal por incompatibilidade fetomaternal no sistema abo

Info

Publication number
BRPI0923032A2
BRPI0923032A2 BRPI0923032A BRPI0923032A BRPI0923032A2 BR PI0923032 A2 BRPI0923032 A2 BR PI0923032A2 BR PI0923032 A BRPI0923032 A BR PI0923032A BR PI0923032 A BRPI0923032 A BR PI0923032A BR PI0923032 A2 BRPI0923032 A2 BR PI0923032A2
Authority
BR
Brazil
Prior art keywords
globulin
igg
fetal
concentrate
antibody
Prior art date
Application number
BRPI0923032A
Other languages
English (en)
Inventor
Mazen Elzaabi
Original Assignee
Français Du Fractionnement Et Des Biotechnologies Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Français Du Fractionnement Et Des Biotechnologies Lab filed Critical Français Du Fractionnement Et Des Biotechnologies Lab
Publication of BRPI0923032A2 publication Critical patent/BRPI0923032A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
BRPI0923032A 2008-12-17 2009-12-16 utilização de um concentrado de imuno globulinas g (igg) pobre em anticorpos anti-a e anti-b para o tratamento do icterícia neonatal por incompatibilidade fetomaternal no sistema abo BRPI0923032A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0807105A FR2939667B1 (fr) 2008-12-17 2008-12-17 Composition d'immunoglobine g comme medicament pour le traitement de l'ictere neonatal par incompatibilite foetomaternelle dans le systeme abo
PCT/FR2009/052558 WO2010076496A1 (fr) 2008-12-17 2009-12-16 Utilisation d'un concentre d'immunoglobulines g (igg) appauvri en anticorps anti-a et anti-b pour le traitement de l'ictere neonatal par incompatibilite foetomaternelle dans le systeme abo

Publications (1)

Publication Number Publication Date
BRPI0923032A2 true BRPI0923032A2 (pt) 2015-12-15

Family

ID=40844436

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0923032A BRPI0923032A2 (pt) 2008-12-17 2009-12-16 utilização de um concentrado de imuno globulinas g (igg) pobre em anticorpos anti-a e anti-b para o tratamento do icterícia neonatal por incompatibilidade fetomaternal no sistema abo

Country Status (13)

Country Link
US (1) US20120039886A1 (pt)
EP (1) EP2358391B1 (pt)
JP (2) JP2012512235A (pt)
KR (1) KR20110128271A (pt)
CN (2) CN102316899A (pt)
BR (1) BRPI0923032A2 (pt)
CA (1) CA2748562A1 (pt)
DK (1) DK2358391T3 (pt)
ES (1) ES2528420T3 (pt)
FR (1) FR2939667B1 (pt)
IL (1) IL213618A0 (pt)
PL (1) PL2358391T3 (pt)
WO (1) WO2010076496A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2939667B1 (fr) * 2008-12-17 2012-01-27 Fractionnement Et Des Biotechonologies Lab Franc Composition d'immunoglobine g comme medicament pour le traitement de l'ictere neonatal par incompatibilite foetomaternelle dans le systeme abo
AU2013203043B2 (en) 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
FR3018450B1 (fr) * 2014-03-11 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de proteines plasmatiques humaines
US10697983B2 (en) 2015-09-08 2020-06-30 Merck Patent Gmbh Methods of evaluating quality of media suitable for removing anti-A or anti-B antibodies
US10697982B2 (en) 2015-09-08 2020-06-30 Merck Patent Gmbh Methods of evaluating quality of a chromatography media which binds anti-A or anti-B antibodies
CN106267423B (zh) * 2016-07-01 2019-02-19 翁炳焕 人Rh阳性红细胞吸附器
CN106110421B (zh) * 2016-07-01 2019-02-01 翁炳焕 恒河猴红细胞吸附器

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4764369A (en) 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
JPH0655223B2 (ja) * 1986-05-06 1994-07-27 宇部興産株式会社 非生物学的吸着剤
JPH0723319B2 (ja) * 1986-05-14 1995-03-15 株式会社ミドリ十字 血液製剤から血液型抗体を除去する方法
JPH03163029A (ja) * 1989-08-09 1991-07-15 Green Cross Corp:The 新生児溶血性黄疸治療剤
FR2706466B1 (fr) 1993-06-14 1995-08-25 Aetsrn Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré.
US6030614A (en) * 1994-05-13 2000-02-29 Plasmaselect Gmbh Teterow Ameliorating immunological rejection of allograft
KR100501263B1 (ko) 1998-06-09 2005-07-18 스태튼스 세룸 인스티튜트 정맥 주사용 면역글로불린의 제조 방법 및 그 외의 면역글로불린 제품
FR2794461B1 (fr) 1999-06-07 2004-01-23 Lab Francais Du Fractionnement Procede de preparation de nouvelles fractions d'ig humaines possedant une activite immunomodulatrice
FR2824568B1 (fr) 2001-05-11 2004-04-09 Lab Francais Du Fractionnement Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique
FR2853551B1 (fr) 2003-04-09 2006-08-04 Lab Francais Du Fractionnement Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
FR2895263B1 (fr) * 2005-12-26 2008-05-30 Lab Francais Du Fractionnement Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives
FR2939667B1 (fr) * 2008-12-17 2012-01-27 Fractionnement Et Des Biotechonologies Lab Franc Composition d'immunoglobine g comme medicament pour le traitement de l'ictere neonatal par incompatibilite foetomaternelle dans le systeme abo

Also Published As

Publication number Publication date
JP2016041754A (ja) 2016-03-31
AU2009334626A1 (en) 2011-08-11
EP2358391A1 (fr) 2011-08-24
KR20110128271A (ko) 2011-11-29
CN104721819A (zh) 2015-06-24
IL213618A0 (en) 2011-07-31
PL2358391T3 (pl) 2015-05-29
CN102316899A (zh) 2012-01-11
US20120039886A1 (en) 2012-02-16
FR2939667A1 (fr) 2010-06-18
ES2528420T3 (es) 2015-02-09
JP2012512235A (ja) 2012-05-31
WO2010076496A1 (fr) 2010-07-08
FR2939667B1 (fr) 2012-01-27
EP2358391B1 (fr) 2014-12-10
CA2748562A1 (fr) 2010-07-08
DK2358391T3 (en) 2015-03-02

Similar Documents

Publication Publication Date Title
BRPI0923032A2 (pt) utilização de um concentrado de imuno globulinas g (igg) pobre em anticorpos anti-a e anti-b para o tratamento do icterícia neonatal por incompatibilidade fetomaternal no sistema abo
DK1968634T3 (da) Fremgangsmåde til fremstilling af et immunglobulin G (IgG)-koncentrat med formindsket indhold af anti-A- og anti-B-stoffer
WO2014159822A3 (en) Human antibodies to respiratory syncytial virus f protein and methods of use thereof
BRPI0922867A2 (pt) proteina de fusao (f) de virus sincicial respiratorio (rsv) e metodos para seu uso
EP2770927A4 (en) SYSTEM FOR MAINTAINING INTERSEGMENTAL MOVEMENTS FOR USE IN THE SPINE AND METHOD FOR ITS USE
PL2594588T3 (pl) Przeciwciało przeciwko adrenomedulinie (ADM) lub fragment przeciwciała anty-ADM lub szkielet białkowy niestanowiący Ig anty-ADM do zastosowania w terapii
PL2083863T3 (pl) Przeciwciała przeciwko TGF-beta do stosowania w leczeniu niemowląt obarczonych ryzykiem rozwinięcia się dysplazji oskrzelowo-płucnej
BRPI0822318A2 (pt) Sistema de respiração em aeronave usando obogs
HK1144553A1 (en) Use of an acetylsalicylic acid salt for the treatment of viral infections
ZA201204106B (en) Monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber layer degeneration
ZA201309030B (en) System and method for quantifying the presence of components in vehicle exhaust
BR112014029705A2 (pt) composto ou sal, medicamento, métodos para inibir quinase de janus em um mamífero, e para a profilaxia ou tratamento de doenças autoimunes, e, uso de um composto ou sal
BR112014027991A2 (pt) agentes para neutralização de influenza
IT1403312B1 (it) Sistema di assistenza al conducente e procedimento per l'assistenza al conducente per la guida automatica
BR112014004752A2 (pt) processo para a preparação de sulfatos e/ou sulfonatos em um sistema de microrreação
HK1201225A1 (en) Single stage filtration system and method for use with blood processing systems
WO2008131431A3 (en) Modulation of blood brain barrier protein expression
ZA201305266B (en) Robo1-fc fusion protein for use in the treatment of hepatocarcinoma
EP2774635A4 (en) SEPARATION MEMBRANE FOR BLOOD TREATMENT, AND BLOOD TREATMENT APPARATUS WITH SUCH AN INTEGRATED MEMBRANE
PL2687281T3 (pl) Układ i sposób absorpcji poszczególnych składników w gazach
EP2732288A4 (en) BIOLOGICAL MICROCHIP TO ESTIMATE THE CONCENTRATION OF IMMUNOGLOBULIN E AND G IN HUMAN BLOOD, TEST METHOD AND REAGENT SET THEREFOR
CL2008000139A1 (es) Modificacion de cristales de astaxantina; proceso de preparacion; formulacion que la comprende; proceso para producir la formulacion; y uso para la nutricion humana o animal.
WO2012110968A3 (en) Treatment of fistulizing crohn's disease
BR112013009861A2 (pt) compostos para uso em imagem, diagnóstico e/ou tratamento de doenças do sistema nervoso central
AU2009334626B2 (en) Use of an immunoglobulin G (IgG) concentrate depleted of anti-A and anti-B antibodies for treating neonatal jaundice caused by maternal-foetal incompatibility with respect to the ABO system

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]